A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 Apr. 19];8(1):s312. Available from: https://skin.dermsquared.com/skin/article/view/2448